X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (32) 32
life sciences & biomedicine (30) 30
humans (29) 29
nitrogen-containing bisphosphonates (27) 27
nitrogen-containing bisphosphonate (18) 18
diphosphonates - pharmacology (15) 15
phosphonates (13) 13
female (11) 11
animals (10) 10
diphosphonates - chemistry (10) 10
bisphosphonate (9) 9
osteoporosis (9) 9
dentistry (8) 8
pharmacology & pharmacy (8) 8
γδ t cells (8) 8
analysis (7) 7
cell line, tumor (7) 7
diphosphonates - adverse effects (7) 7
endocrinology & metabolism (7) 7
bisphosphonates (6) 6
bone density conservation agents - administration & dosage (6) 6
bone density conservation agents - adverse effects (6) 6
dentistry, oral surgery & medicine (6) 6
diphosphonates - administration & dosage (6) 6
farnesyl pyrophosphate synthase (6) 6
geranyltranstransferase - antagonists & inhibitors (6) 6
male (6) 6
phosphates (6) 6
cancer immunotherapy (5) 5
diphosphonates - therapeutic use (5) 5
immunology (5) 5
zoledronic acid (5) 5
alendronate (4) 4
alendronate - pharmacology (4) 4
apoptosis (4) 4
apoptosis - drug effects (4) 4
biochemistry & molecular biology (4) 4
breast cancer (4) 4
cancer (4) 4
cell biology (4) 4
enzymes (4) 4
geranyltranstransferase - metabolism (4) 4
imidazoles - administration & dosage (4) 4
imidazoles - pharmacology (4) 4
medicine & public health (4) 4
mice (4) 4
middle aged (4) 4
nitrogen (4) 4
oncology (4) 4
orthopedics (4) 4
review (4) 4
adult (3) 3
aged (3) 3
aged, 80 and over (3) 3
bone density conservation agents - pharmacology (3) 3
bone diseases (3) 3
bone metastases (3) 3
bones (3) 3
breast neoplasms - pathology (3) 3
bronj (3) 3
care and treatment (3) 3
cell differentiation - drug effects (3) 3
cell line (3) 3
diphosphonates (3) 3
dose-response relationship, drug (3) 3
ecm, extracellular matrix (3) 3
endocrinology, diabetes and metabolism (3) 3
enzyme inhibitors - chemistry (3) 3
geranyltranstransferase - chemistry (3) 3
gfp, green fluorescent protein (3) 3
histology (3) 3
imidazoles - adverse effects (3) 3
imidazoles - therapeutic use (3) 3
immunotherapy (3) 3
injections, intravenous (3) 3
medicine, research & experimental (3) 3
metastasis (3) 3
mevalonate pathway (3) 3
mice, inbred balb c (3) 3
nbp, nitrogen-containing bisphosphonate (3) 3
nitrogen containing bisphosphonates (3) 3
nitrogen‐containing bisphosphonates (3) 3
osteoclasts - drug effects (3) 3
osteoporosis - drug therapy (3) 3
receptors, antigen, t-cell, gamma-delta - immunology (3) 3
research & experimental medicine (3) 3
research article (3) 3
review article (3) 3
rna, messenger - metabolism (3) 3
smad3 (3) 3
treatment outcome (3) 3
tumors (3) 3
actriia, activin-a type iia receptor (2) 2
administration, oral (2) 2
adoptive immunotherapy (2) 2
alendronate - administration & dosage (2) 2
alendronate - adverse effects (2) 2
aminobisphosphonate (2) 2
anemia (2) 2
antineoplastic agents - pharmacology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bone (New York, N.Y.), ISSN 8756-3282, 07/2011, Volume 49, Issue 1, pp. 34 - 41
Journal Article
Journal Article
Bone, ISSN 8756-3282, 2015, Volume 81, pp. 478 - 486
Journal Article
Journal of biomedical science, ISSN 1021-7770, 02/2014, Volume 21, Issue 1, pp. 10 - 10
Journal Article
Journal of diabetes and metabolic disorders, ISSN 2251-6581, 2014, Volume 13, Issue 1, pp. 109 - 109
Although for many decades bisphosphonates were used for adult bone loss, bisphosphonate administration in pediatric patients is new and was initiated in the past 15-year... 
Bisphosphonate | Osteogenesis imperfecta | Pediatric osteoporosis | Pediatric bone loss | Pediatric bone malignancy | Nitrogen-containing bisphosphonate | Corticoid-induced osteoporosis | Osteoporosis | Eating disorders | Review
Journal Article
ChemMedChem, ISSN 1860-7187, 01/2019, Volume 14, Issue 4, pp. 462 - 468
Immune checkpoint blockade using anti‐PD‐1/PD‐L1 or anti‐CTLA‐4 monoclonal antibodies (mAbs) has revolutionized cancer treatment. However, many types of cancer... 
nitrogen-containing bisphosphonates | Vγ2Vδ2 γδ T cells | cancer immunotherapy | non-radioactive cellular cytotoxicity assays | fluorine | Vγ2Vδ2 γδ T cells | Intraepithelial Lymphocytes - drug effects | Intraepithelial Lymphocytes - metabolism | Intraepithelial Lymphocytes - cytology | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Immunologic Factors - chemical synthesis | Animals | Lymphocyte Activation - drug effects | Diphosphonates - chemistry | Immunotherapy | Cell Line, Tumor | Diphosphonates - therapeutic use | Prodrugs - chemical synthesis | Mice | Prodrugs - therapeutic use | Prodrugs - pharmacology | Diphosphonates - pharmacology | Fluorine - chemistry | Immunologic Factors - pharmacology | Monoclonal antibodies | Fluorides | Metabolites | T cells | Phosphonates | Peptides | Fluorine | Toxicity | Effector cells | Cytotoxicity | Lymphocytes T | Bisphosphonates | Immunosuppressive agents | Receptors | Lymphocytes | Peripheral blood | Zoledronic acid | Butyrophilin | Immunomodulation | Analogue | Tumor cells | T cell receptors | Hemopoiesis | Major histocompatibility complex | Immune checkpoint | Isopentenyl diphosphate | Cancer | Tumors | Index Medicus | non-radioactive cellular cytotoxicity assay | nitrogen-containing bisphosphonate
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2009, Volume 67, Issue 9, pp. 1904 - 1913
Journal Article
Journal Article